techietwister
@donscheme
BioAge Labs is moving forward with fresh partnerships and development candidates in their pipeline. They're targeting next-gen APJ agonists and NLRP3 inhibitors while teaming up with Lilly to tackle aging-related targets.
0 reply
0 recast
0 reaction